Oscar Health (OSCR)
(Delayed Data from NYSE)
$20.63 USD
-0.58 (-2.73%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $20.62 -0.01 (-0.05%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$20.63 USD
-0.58 (-2.73%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $20.62 -0.01 (-0.05%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth A Momentum A VGM
Zacks News
New Strong Buy Stocks for October 20th
by Zacks Equity Research
OSCR, IMGN, AFRM, ACVA and SOLO have been added to the Zacks Rank #1 (Strong Buy) List on October 20, 2023.
Reasons to Hold American International (AIG) Stock for Now
by Zacks Equity Research
Strong General Insurance business, improving premiums and cost-cutting efforts poise American International (AIG) well for growth.
Here's Why You Should Retain MetLife (MET) in Your Portfolio
by Zacks Equity Research
MetLife's (MET) growing partnerships, strong U.S. and Latin America segments, and cost-cutting efforts are aiding its margins.
Oscar Health, Inc. (OSCR) Stock Jumps 56.3%: Will It Continue to Soar?
by Zacks Equity Research
Oscar Health, Inc. (OSCR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Why Investors Should Invest in CNO Financial (CNO) Stock Now
by Zacks Equity Research
Strong direct-to-consumer life sales, improving annuity collected premiums and increased Medicare enrolment poise CNO Financial (CNO) well for growth.
Do Options Traders Know Something About Oscar Health (OSCR) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Oscar Health (OSCR) stock based on the movements in the options market lately.
Oscar Health, Inc. (OSCR) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Oscar Health, Inc. (OSCR) delivered earnings and revenue surprises of -3.96% and 10.73%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Prudential (PRU) Misses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Prudential (PRU) delivered earnings and revenue surprises of -5.84% and 1.06%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Strength Seen in Lemonade (LMND): Can Its 12.8% Jump Turn into More Strength?
by Zacks Equity Research
Lemonade (LMND) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Old Republic International (ORI) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Old Republic (ORI) delivered earnings and revenue surprises of 63.27% and 1.90%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Oscar Health, Inc. (OSCR) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Oscar Health, Inc. (OSCR) delivered earnings and revenue surprises of -19.74% and 5.08%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Cigna (CI) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Cigna (CI) delivered earnings and revenue surprises of 5.96% and 1.10%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
American International Group (AIG) Q3 Earnings Surpass Estimates
by Zacks Equity Research
American International Group (AIG) delivered earnings and revenue surprises of 11.86% and 1.50%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
PCB Bancorp (PCB) Q3 Earnings Miss Estimates
by Zacks Equity Research
PCB Bancorp (PCB) delivered earnings and revenue surprises of -32.35% and 2.06%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Cigna (CI) & Oscar Health Boost Presence in Philadelphia
by Zacks Equity Research
Cigna (CI) & Oscar Health's plans are likely to target businesses with 1-50 employees.
Cigna (CI) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Cigna (CI) delivered earnings and revenue surprises of 14.34% and 2.73%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Trean Insurance (TIG) Surpasses Q2 Earnings Estimates
by Zacks Equity Research
Trean Insurance (TIG) delivered earnings and revenue surprises of 120% and 4.23%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
EverQuote (EVER) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
EverQuote (EVER) delivered earnings and revenue surprises of 74.47% and 7.15%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Is MetLife (MET) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Are Investors Undervaluing Cigna (CI) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is MGIC Investment (MTG) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Oscar Health, Inc. (OSCR) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Oscar Health, Inc. (OSCR) delivered earnings and revenue surprises of 10% and 21.14%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Lemonade (LMND) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Lemonade (LMND) delivered earnings and revenue surprises of 15.38% and 2.43%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Horace Mann (HMN) Q1 Earnings Lag Estimates
by Zacks Equity Research
Horace Mann (HMN) delivered earnings and revenue surprises of -31.91% and 2.06%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Goosehead Insurance (GSHD) Q1 Earnings Beat Estimates
by Zacks Equity Research
Goosehead (GSHD) delivered earnings and revenue surprises of 300% and 0.99%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?